Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02034175 · ClinicalTrials.gov registry record · NA

Comparison of SomnaPatch With Polysomnography in Sleep Disordered Breathing

A NA study of Obstructive Sleep Apnea and Central Sleep Apnea, sponsored by Somnarus.

Completed
Registry status
NA
Development phase
190
Enrollment target
3
Study locations

NCT02034175 is a NA study of Obstructive Sleep Apnea and Central Sleep Apnea that has completed, run by Somnarus. The registered enrollment target is 190 participants, below the 220-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (14% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02034175, a NA study of Obstructive Sleep Apnea and Central Sleep Apnea, has completed, sponsored by Somnarus.

COMPLETED
Registry status
NA
Development phase
190 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to evaluate the accuracy of Somnarus diagnostic technology for diagnosis of sleep apnea in human subjects. This includes evaluation of Somnarus technology in Obstructive Sleep Apnea (OSA) and Central Sleep Apnea (CSA), including Cheyne - Stokes respiration (CSR).

Interventions

  • DEVICE Polysomnography
  • DEVICE SomnaPatch

Study Locations (3)

Arkansas

  • Preferred Research Partners, Inc - Little Rock

California

  • Peninsula Sleep Center - Burlingame

Florida

  • The Good Sheperd Sleep Center, LLC - Tampa

Trial Details

FieldValue
Enrollment Target 190 participants
Start Date 2016-02-01
Est. Completion 2016-11-30
Phase NA

Sponsor

Somnarus

1 total trials

What the Registry Record Tells You About NCT02034175

The ClinicalTrials.gov registry entry for NCT02034175 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 190 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 220-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (14% lower). The listed sponsor is Somnarus, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 2 interventions - of which Polysomnography is the first listed.

NCT02034175 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Arkansas, California, Florida.

Frequently Asked Questions

What is clinical trial NCT02034175 about?

NCT02034175 is a clinical study titled "Comparison of SomnaPatch With Polysomnography in Sleep Disordered Breathing". The purpose of this study is to evaluate the accuracy of Somnarus diagnostic technology for diagnosis of sleep apnea in human subjects. This includes evaluation of Somnarus technology in Obstructive Sleep Apnea (OSA) and Central Sleep Apnea (CSA), including Cheyne - Stokes respiration (CSR).

What is the current status of trial NCT02034175?

This trial is currently completed. It is a NA study. The enrollment target is 190 participants. The study started on 2016-02-01. Estimated completion is 2016-11-30.

What conditions does trial NCT02034175 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea, Central Sleep Apnea, Cheyne-Stokes Respiration, Mixed Sleep Apnea.

What interventions are being tested in trial NCT02034175?

The interventions under investigation include: Polysomnography (DEVICE), SomnaPatch (DEVICE).

Who is sponsoring clinical trial NCT02034175?

This trial is sponsored by Somnarus, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02034175 being conducted?

This trial has 3 study locations across Arkansas, California, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.